MD 3255 | 2014
Medical Devices
Coagulation/Hemostasis Analyzer Market by Product (Automated, POC), Consumables (Reagents, Standards), Test Type (APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, Optical), End Users (Research Institutes, Hospitals)
Forecast to 2019 Report Description
Table of Contents List of Tables Sample Tables Related Reports
MarketsandMarkets North - Dominion Plaza, 17304, Preston Road, Suite 800, Dallas, TX 75252, U.S. Tel. No.: 1-888-600-6441 Email: sales@marketsandmarkets.com Website: www.marketsandmarkets.com
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
MD 3255
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers fourteen industry verticals, including aerospace and defence, advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
Copyright Š 2014 MarketsandMarkets All Rights Reserved. This document contains highly confidential information and is the sole property of MarketsandMarkets. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of MarketsandMarkets.
1 Š MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
1
INTRODUCTION
1.1
OBJECTIVES OF THE STUDY
1.2
MD 3255
To define, describe, and forecast the global coagulation analyzers market on the basis of product, test, technology, end user, and region
To provide detailed information regarding major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of the global coagulation analyzers market with respect to four main regions (along with countries), namely, North America, Europe, Asia-Pacific, and Rest of the World
To strategically profile key players in the global coagulation analyzers market and comprehensively analyze their core competencies2 and market shares
To track and analyze competitive developments such as agreements, partnerships, and alliances; acquisitions; new product developments; expansions; and R&D activities in the global coagulation analyzers market
MARKET DEFINITION
Coagulation analyzers and reagents are used to evaluate the coagulation profiles of blood samples, which are utilized for clotting-based or chromogenic assays and for diagnosing clotting factor deficiencies. Thus, they are primarily used in wound, injury, and post-operative management.
1. Micromarkets are defined as further segments and subsegments of the global coagulation analyzers market included in the report. 2. Core competencies of the companies are captured in terms of their key developments, SWOT analyses, and key strategies adopted to sustain their positions in the market.
2 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
1.3
MD 3255
MARKET SCOPE
1.3.1
MARKETS COVERED
This research report divides the coagulation analyzers market into the following segments:
FIGURE 1
COAGULATION ANALYZERS MARKET, BY PRODUCT
COAGULATION ANALYZERS MARKET, BY PRODUCT
Clinical Laboratory Analyzers
Point-of-Care Testing Analyzers
Instruments Automated Analyzers Semi-automated and Manual Analyzers
Consumables Reagents Standards, Calibrators and Controls
Global Hemostasis/Coagulation Analyzers Market, by Product
Clinical Laboratory Analyzers
Instruments
Automated Analyzers
Semi-automated and Manual Analyzers
Consumables
Reagents
Standards, Calibrations and Controls
Point-of-Care Testing Analyzers
Global Hemostasis/Coagulation Analyzers Market, by Test
Activated Partial Thromboplastin Time (APTT)
Prothrombin Time (PT/INR)
D-Dimer
Fibrinogen
Others
3 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
MD 3255
Global Hemostasis/Coagulation Analyzers Market, by Technology
Mechanical
Optical
Electrochemical
Others
Global Hemostasis/Coagulation Analyzers Market, by End User
Research Institutes
Diagnostic laboratories
Standalone Hospitals
Others
Global Hemostasis/Coagulation Analyzers Market, by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
4 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
1.3.2
YEARS CONSIDERED FOR THE STUDY
PARAMETER
SCOPE
2013
Base Year
2012
Historical Year
2014–2019
Forecast Period
2013
Base Year Used for Company Profiles
1.4
MD 3255
CURRENCY
The currency used in this report is USD ($), with market size indicated in $million.
For companies reporting their revenue in USD, revenues were picked from their annual reports
For companies that reported their revenues in other currencies, the average annual currency conversion rate was used for the particular year to convert the value to USD
1.5
LIMITATIONS
The report does not cover country-level quantitative information (value market) for the RoW market due to the availability of limited information from primary and secondary sources. However, the report provides country-level qualitative information
The volume market is not included in the report due to limited information available from secondary as well as primary sources
1.6
STAKEHOLDERS
Coagulation Product Manufacturers and Suppliers
Hospitals
Clinical Testing Laboratories
Research and Development (R&D) Companies
Business Research and Consulting Service Providers
Medical Research Laboratories
Academic Medical Centers and Universities
5 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
2
RESEARCH METHODOLOGY
2.1
RESEARCH DATA
MD 3255
This research study involved the usage of extensive secondary sources; directories; databases such as Hoovers, Bloomberg Businessweek, Factiva, and OneSource; white papers; annual reports; company house documents; and SEC filings of companies. Secondary research was mainly used to identify and collect information useful for an extensive, technical, market-oriented, and commercial study of the global coagulation analyzers market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, regional markets, and developments related to the market and technology perspectives. Primary sources involved in this research study are industry experts from the core and related industries; preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and laboratory technicians; and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted from various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify critical qualitative and quantitative information as well as to assess future growth prospects. The following figure shows the market research methodology applied in making this report.
FIGURE 2
RESEARCH DESIGN
HISTORICAL DATA FOR THE COAGULATION ANALYZERS MARKET
Market Share Analysis
Regulatory Landscape
Competitive Landscape
Evolution
Company Revenues and R&D Expenses
Regional Usage Pattern
MARKET DRIVERS: • Increasing prevalence of diseases and the number of surgical procedures
INFLUENCING FACTORS (Market Trends and Dynamics)
• Increasing adoption of automated coagulation instruments by diagnostic laboratories • Development of high-sensitivity point-of-care (POC) coagulation testing • Technological advancement and new product launches
MARKET RESTRAINTS:
• Slow adoption of advanced coagulation instruments in emerging economies • High cost of fully automated coagulation analyzers
• Increasing aging population
MARKET OPPORTUNITIES:
CHALLENGE:
• Rapid growth of coagulation market in emerging countries such as India, China, and Brazil
• Stringent and timeconsuming regulatory policies
• Increasing number of hemophilic patients
Historical Data of the Market
Market Size & Forecast, by Product, by Test, and Technology
Impact Analysis of Market Trends
Market Size & Forecast, by End User
FORECAST
Arrive at the Market Size, Share and CAGR for the Coagulation Analyzers Market
6 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
MD 3255
In the secondary research process, various secondary sources were referred to for identifying and collecting information useful for this study. These secondary sources include annual reports, press releases, investor presentations of companies, white papers, medical device journals, certified publications, articles from recognized authors, gold standard and silver standard websites, directories, and databases. Secondary research was mainly used to obtain key information about the industry‘s supply chain, leading and emerging players, market classification and segmentation according to industry trends to the bottommost level, geographical markets, and key developments from both market and technology-oriented perspectives. In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply-side include industry experts, such as CEOs, vice-presidents, marketing directors, technology and innovation directors; and related key executives from key companies and organizations operating in the market. Primary sources from the demand-side include coagulation analyzers manufacturers, R&D professionals, and technicians. After complete market engineering (which includes calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and to verify and validate the critical numbers arrived at. Primary research was also conducted to identify and study segmentation types; industry trends; Porter’s analysis; key players; competitive landscape for the coagulation analyzers market, and the end-products supplied by different market players; and key market dynamics such as drivers, restraints, opportunities, and key player strategies. In the complete market engineering process, both top-down and bottom-up approaches were extensively used along with several data triangulation methods to perform market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list key information/insights throughout the report.
2.2
MARKET SIZE ESTIMATION
Top-down and bottom-up approaches were used to estimate and validate the size of the global market and various other dependent submarkets. Key players in this market were identified through secondary research and their market shares in respective geographies determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined by using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report. The following figure shows an illustrative representation of the overall market size estimation process employed for the purpose of this study.
7 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
FIGURE 3
MD 3255
TOP-DOWN APPROACH Top-down Approach
Global Coagulation Analyzers Market ($Million)
Global Coagulation Analyzers Market
Global Market Size is Validated Through Primaries (Demand and Supply Side Experts)
Percentage Split for the Segments of the Coagulation Analyzers Market
Regional Split
Regional and Country-wise Market for Each Segment
FIGURE 4
PRIMARY: Demand and Supply Side Experts
SECONDARY: Annual Reports, Presentations, Press Release, Journals, Paid Databases, Company Websites, News Articles, and MarketsandMarkets Repository
BOTTOM-UP APPROACH Bottom-up Approach
Global Coagulation Analyzers Market
Global Coagulation Analyzers Market
Shares of Company Revenues in the Overall Market
Company-wise Revenue
PRIMARY: Demand and Supply Side Experts SECONDARY: Annual Reports, Presentations, Press Release, Journals, Paid Databases, and MarketsandMarkets Repository
8 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
MD 3255
The bottom-up procedure was adopted to arrive at the overall market size of the global coagulation analyzers market from the revenue of key players (companies) and their shares in the market and annual sales of coagulation analyzers, based on the type of product. Calculations based on the revenue of key companies and sales of coagulation analyzers identified in the market led to the overall market size. This overall market size was used in the top-down procedure to estimate the size of other individual markets through percentage splits from secondary and primary research. For the calculation of each type of specific market segment, the most appropriate immediate parent market size was used for implementing the top-down procedure. The bottom-up procedure was also implemented to validate market segment revenues obtained from data extracted from secondary research. Market shares were then estimated for each company to verify revenue shares used earlier in the bottomup procedure. With the data triangulation procedure and the validation of data through primaries, the exact values of the overall parent market size and each individual market size were determined and confirmed in this study. The data triangulation procedure implemented for this study is explained in the next section.
FIGURE 5
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION NUMBER OF PRIMARIES: BY COMPANY TYPE
NUMBER OF PRIMARIES: BY DESIGNATION
NUMBER OF PRIMARIES: BY REGION
XX XX XX
XX
XX
XX XX
XX
Tier 1 Companies Tier 3 Companies
XX Tier 2 Companies
C-Level
Director-Level
XX
Others
North America
Europe
Asia-Pacific
RoW
Note: *Others include sales managers, marketing managers, and product managers Company tiers are defined on the basis of their total revenue, as of 2013; Tier 1 = > $XX Billion, Tier 2 = $XX Million-$XX Billion, and Tier 3 = < $XX Million
9 Š MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
2.3
MD 3255
MARKET BREAKDOWN AND DATA TRIANGULATION
After arriving at the overall market size from the market size estimation process explained above, the total market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics for all the segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. Data was triangulated by studying various factors and trends from both the demand and supply sides. Along with this, the market was validated using both top-down and bottom-up approaches.
FIGURE 6
DATA TRIANGULATION METHODOLOGY PRIMARY SOURCES
SECONDARY SOURCES
DEMAND SIDE
Interviews with: • Chief Information Officers
• Technicians, Technologists, Physicians, and Nurses • Purchase Managers in Healthcare Provider Organizations
Annual Reports, Investor Presentations, Websites and Press Releases of Top Players, News Articles, Journals, and Paid Databases
• •
World Health Organization (WHO) Centers for Disease Control and Prevention (CDC) National Institutes of Health (NIH)
MnM KNOW*
Interviews with: • CEOs and Vice-presidents
SUPPLY SIDE
•
PRIMARY SOURCE
• Marketing Directors
DATA TRIANGULATION SECONDARY SOURCE
• Technology and Innovation Directors and Related Key Executives From Various Key Companies and Organizations Operating in the Coagulation Analyzers Market
•
INFORMATION SOURCED
Key Players
Competitive Landscape
Drivers/Restraints
Opportunities/Challenges
Forecasting
Market Size (2014) and Market Share (2014)
Region-wise Analysis
MnM KNOW* stands for MarketsandMarkets’ 'Knowledge Asset Management' framework. In this context, it stands for an existing market research knowledge repository of over 5,000 granular markets, our flagship competitive intelligence and market research platform "RT", subject matter experts, and independent consultants. MnM KNOW acts as an independent source that helps us validate information gathered from primary and secondary sources .
Note: MnM KNOW* stands for ‘MarketsandMarkets Knowledge Asset Management' framework. In this context, it stands for existing market research knowledge repository of over 5,000 granular markets, our flagship competitive intelligence and market research platform "RT", subject matter experts, and independent consultants. MnM KNOW acts as an independent source that helps us validate information gathered from primary and secondary sources.
10 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
2.4
MD 3255
MARKET SHARE ESTIMATION
The market shares for key players have been calculated based on secondary data available through paid and unpaid sources and by analyzing the product portfolios of the top companies. This data was further validated through expert interviews.
2.5
KEY DATA FROM SECONDARY SOURCES SECONDARY SOURCES
DATA
Market Size
• • • • • •
Company Financials Magazines Journals Press Releases Paid Databases MarketsandMarkets Data Repository
Revenue of Companies
• • • •
Annual Reports Company Websites Public Databases MarketsandMarkets Data Repository
Qualitative Information (Market Dynamics and Trends)
• • • •
Company Websites Annual Reports Press Releases MarketsandMarkets Data Repository
11 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
2.6
MD 3255
KEY DATA FROM PRIMARY SOURCES
TYPES
Regional Split
Global Market Size
PARAMETERS •
Overall market and segments in 2014
•
CAGR of each region in the forecast period (2014–2019)
•
Global market size for 2014
•
CAGR for the forecast period (2014–2019)
•
Clinical Laboratory Analyzers and Pointof-Care Testing Analyzers
•
Activated Partial Thromboplastin Time (APTT), Prothrombin Time (PT/INR), DDimer, Fibrinogen, Others
Market Split •
•
Mechanical, Optical, Electrochemical, and Others Standalone Hospitals, Diagnostic Laboratories, Research Institutes, and other end users
DATA Global coagulation analyzers market, by region–North America, Europe, Asia, and RoW
Global coagulation analyzers market Coagulation analyzers market, by segment Coagulation analyzers market, by product, test, technology, and end user
Coagulation analyzers market, by product Coagulation analyzers market, by type of test Coagulation analyzers market, by technology Coagulation analyzers market, by end user
12 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
2.7
MD 3255
KEY INDUSTRY INSIGHTS
“Consumables will be a major market in the global clinical laboratory analyzers market.” – President and CEO,
“The average growth rate for the global coagulation analyzers market will be around XX% to XX%.”
Leading Company
– CEO, Leading Coagulation Analyzers Company
“The market for point-of-care testing coagulation analyzers is currently smaller as compared that of Clinical Laboratory Analyzers ; however, this market is expected to grow at a higher rate in the next five years due to technological advancements and investments by companies.” – Sales Director, Leading
“Emerging markets such as India and China are new avenues for growth of the coagulation analyzers market due to the major interest of companies in these regions.” –CEO, Leading Coagulation Analyzers Company
Coagulation Analyzers Manufacturing Company
2.8
ASSUMPTIONS FOR THE STUDY
The following assumptions were taken into consideration to complete the overall market engineering of the coagulation analyzers market:
PARAMETERS
Market Growth
ASSUMPTIONS The CAGR for the forecast period is assumed to be normalized and the effect of inflation, recession, economic downturn, regulatory or policy changes, or other factors are not considered.
13 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
MD 3255
TABLE OF CONTENTS 1
2
3
INTRODUCTION ........................................................................................................ 18 1.1
OBJECTIVES OF THE STUDY ...........................................................................................................18
1.2
MARKET DEFINITION .....................................................................................................................18
1.3
MARKET SCOPE............................................................................................................................18
5
MARKETS COVERED ....................................................................................................... 18
1.3.2
YEARS CONSIDERED FOR THE STUDY .............................................................................. 20
1.4
CURRENCY ...................................................................................................................................21
1.5
LIMITATIONS ................................................................................................................................21
1.6
STAKEHOLDERS ...........................................................................................................................21
RESEARCH METHODOLOGY ...................................................................................... 22 2.1
RESEARCH DATA ..........................................................................................................................22
2.2
MARKET SIZE ESTIMATION ............................................................................................................23
2.3
MARKET BREAKDOWN AND DATA TRIANGULATION ........................................................................25
2.4
MARKET SHARE ESTIMATION ........................................................................................................27
2.5
KEY DATA FROM SECONDARY SOURCES .......................................................................................27
2.6
KEY DATA FROM PRIMARY SOURCES ............................................................................................28
2.7
KEY INDUSTRY INSIGHTS ..............................................................................................................28
2.8
ASSUMPTIONS FOR THE STUDY ....................................................................................................29
EXECUTIVE SUMMARY .............................................................................................. 30 3.1
4
1.3.1
INTRODUCTION ............................................................................................................................30
PREMIUM INSIGHTS ................................................................................................ 35 4.1
HIGH GROWTH POTENTIAL OF THE COAGULATION ANALYZERS MARKET..........................................35
4.2
GLOBAL CLINICAL LABORATORY ANALYZERS, BY TYPE ...................................................................36
4.3
GLOBAL COAGULATION ANALYZERS MARKET, BY REGION..............................................................37
4.4
COAGULATION ANALYZERS MARKET, BY INSTRUMENT...................................................................38
4.5
COAGULATION ANALYZERS MARKET, BY TEST ................................................................................39
4.6
GLOBAL COAGULATION ANALYZERS MARKET, BY END USER ..........................................................40
4.7
LIFECYCLE ANALYSIS, BY REGION .................................................................................................41
MARKET OVERVIEW.................................................................................................. 42 5.1
INTRODUCTION ............................................................................................................................43
5.2
MARKET SEGMENTATION ..............................................................................................................43 5.2.1
COAGULATION ANALYZERS MARKET, BY PRODUCT.......................................................... 43
5.2.2
COAGULATION ANALYZERS MARKET, BY TEST ................................................................. 43
5.2.3
COAGULATION ANALYZERS MARKET, BY TECHNOLOGY .................................................... 44
5.2.4
COAGULATION ANALYZERS MARKET, BY END USER ......................................................... 45 14
© MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
5.2.5
MARKET DYNAMICS......................................................................................................................46
5.4
DRIVERS ......................................................................................................................................47
5.6
5.7
5.4.1
INCREASING PREVALENCE OF DISEASES AND RISING NUMBER OF SURGICAL PROCEDURES ................................................................................................................ 47
5.4.2
INCREASING ADOPTION OF AUTOMATED COAGULATION INSTRUMENTS BY DIAGNOSTIC LABORATORIES .......................................................................................... 48
5.4.3
DEVELOPMENT OF HIGH-SENSITIVITY POINT-OF-CARE (POC) COAGULATION TESTING ......................................................................................................................... 48
5.4.4
GROWTH IN AGING POPULATION..................................................................................... 48
5.4.5
TECHNOLOGICAL ADVANCEMENTS AND NEW PRODUCT LAUNCHES ................................ 49
RESTRAINTS .................................................................................................................................50 5.5.1
SLOW ADOPTION OF ADVANCED COAGULATION INSTRUMENTS IN EMERGING ECONOMIES................................................................................................................... 50
5.5.2
HIGH COST OF FULLY AUTOMATED COAGULATION ANALYZERS ........................................ 50
OPPORTUNITIES ...........................................................................................................................51 5.6.1
RAPID GROWTH IN THE COAGULATION MARKET IN EMERGING ECONOMIES..................... 51
5.6.2
INCREASING NUMBER OF HEMOPHILIC PATIENTS........................................................... 51
CHALLENGE .................................................................................................................................52 5.7.1
7
8
COAGULATION ANALYZERS MARKET, BY REGION ............................................................ 45
5.3
5.5
6
MD 3255
STRINGENT AND TIME-CONSUMING REGULATORY POLICIES ........................................... 52
INDUSTRY INSIGHTS ............................................................................................... 54 6.1
INTRODUCTION ............................................................................................................................54
6.2
PORTER’S FIVE FORCES ANALYSIS ................................................................................................54 6.2.1
THREAT FROM NEW ENTRANTS ....................................................................................... 55
6.2.2
THREAT FROM SUBSTITUTES .......................................................................................... 56
6.2.3
BARGAINING POWER OF SUPPLIERS .............................................................................. 56
6.2.4
BARGAINING POWER OF BUYERS ................................................................................... 56
6.2.5
INTENSITY OF COMPETITIVE RIVALRY .............................................................................. 57
6.3
SUPPLY CHAIN ANALYSIS .............................................................................................................57
6.4
STRATEGIC BENCHMARKING ........................................................................................................59
HEMOSTASIS/COAGULATION ANALYZERS MARKET, BY TYPE OF TEST ........................ 61 7.1
INTRODUCTION ............................................................................................................................62
7.2
PROTHROMBIN TIME (PT/INR) TEST ..............................................................................................63
7.3
ACTIVATED CLOTTING TIME (ACT/APTT) TEST .................................................................................65
7.4
D-DIMER TEST ..............................................................................................................................68
7.5
FIBRINOGEN TEST ........................................................................................................................70
7.6
OTHERS COAGULATION TEST.........................................................................................................72
COAGULATION ANALYZERS MARKET, BY TYPE ........................................................... 76 8.1
INTRODUCTION ............................................................................................................................77
8.2
CLINICAL LABORATORY COAGULATION ANALYZERS .......................................................................78 15
© MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
8.2.1
INSTRUMENTS ............................................................................................................... 81 8.2.1.1
8.2.2
8.3
9
MD 3255
Fully Automated Coagulation Analyzers .............................................................. 85
COAGULATION CONSUMABLES ...................................................................................... 90
POINT-OF-CARE TESTING COAGULATION ANALYZERS ....................................................................97
COAGULATION ANALYZERS MARKET, BY TECHNOLOGY............................................ 101 9.1
INTRODUCTION ..........................................................................................................................102
9.2
PHOTO OPTICAL TECHNOLOGY ....................................................................................................102
9.3
MECHANICAL TECHNOLOGY........................................................................................................103
9.4
ELECTROCHEMICAL TECHNOLOGY ..............................................................................................103
9.5
OTHER TECHNOLOGIES ...............................................................................................................103
10 HEMOSTASIS/COAGULATION ANALYZERS MARKET, BY END USER .......................... 104 10.1
INTRODUCTION ..........................................................................................................................105
10.2
RESEARCH INSTITUTES ...............................................................................................................106
10.3
DIAGNOSTIC LABORATORIES ......................................................................................................109
10.4
STANDALONE HOSPITALS ...........................................................................................................111
10.5
OTHER END USERS .....................................................................................................................113
11 COAGULATION ANALYZERS MARKET, BY REGION .................................................... 117 11.1
INTRODUCTION ..........................................................................................................................118
11.2
NORTH AMERICA ........................................................................................................................121
11.3
11.4
11.5
11.2.1
U.S. .............................................................................................................................127
11.2.2
CANADA.......................................................................................................................131
EUROPE .....................................................................................................................................135 11.3.1
GERMANY ....................................................................................................................139
11.3.2
FRANCE .......................................................................................................................142
11.3.3
U.K. .............................................................................................................................146
11.3.4
ITALY............................................................................................................................149
11.3.5
SPAIN ..........................................................................................................................152
11.3.6
REST OF EUROPE (ROE) ................................................................................................156
ASIA-PACIFIC .............................................................................................................................159 11.4.1
JAPAN ..........................................................................................................................163
11.4.2
CHINA ..........................................................................................................................167
11.4.3
INDIA ...........................................................................................................................170
11.4.4
REST OF ASIA-PACIFIC (ROAPAC) ..................................................................................175
REST OF THE WORLD (ROW) ........................................................................................................178
12 COMPETITIVE LANDSCAPE ..................................................................................... 184 12.1
OVERVIEW ..................................................................................................................................184
12.2
MARKET SHARE ANALYSIS ..........................................................................................................185 12.2.1
MARKET SHARE ANALYSIS FOR CLINICAL LABORATORY ANALYZERS MARKET ................185 16
© MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
12.2.2
12.3
MD 3255
MARKET SHARE ANALYSIS FOR POINT-OF-CARE COAGULATION ANALYZERS MARKET .......................................................................................................................186
COMPETITIVE SITUATION AND TRENDS........................................................................................187 12.3.1
EXPANSIONS................................................................................................................188
12.3.2
NEW PRODUCT LAUNCHES ...........................................................................................189
12.3.3
AGREEMENTS, PARTNERSHIPS, & ALLIANCES ..............................................................190
12.3.4
ACQUISITIONS .............................................................................................................191
12.3.5
OTHER DEVELOPMENTS ...............................................................................................191
13 COMPANY PROFILES .............................................................................................. 193 13.1
INTRODUCTION ..........................................................................................................................193
13.2
SIEMENS HEALTHCARE (A DIVISION OF SIEMENS AG) .................................................................194
13.3
13.4
13.5
13.6
13.7
13.2.1
BUSINESS OVERVIEW...................................................................................................194
13.2.2
SIEMENS AG: COMPANY SNAPSHOT .............................................................................194
13.2.3
PRODUCT PORTFOLIO...................................................................................................195
13.2.4
KEY STRATEGY..............................................................................................................196
13.2.5
RECENT DEVELOPMENTS..............................................................................................196
SYSMEX CORPORATION ..............................................................................................................198 13.3.1
BUSINESS OVERVIEW...................................................................................................198
13.3.2
SYSMEX CORPORATION: COMPANY SNAPSHOT ............................................................198
13.3.3
PRODUCT PORTFOLIO...................................................................................................199
13.3.4
KEY STRATEGIES ..........................................................................................................200
13.3.5
RECENT DEVELOPMENTS..............................................................................................200
ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.) ..........................................202 13.4.1
BUSINESS OVERVIEW...................................................................................................202
13.4.2
ROCHE DIAGNOSTICS: COMPANY SNAPSHOT ...............................................................202
13.4.3
PRODUCT PORTFOLIO...................................................................................................203
13.4.4
KEY STRATEGY..............................................................................................................203
13.4.5
RECENT DEVELOPMENTS..............................................................................................203
NIHON KOHDEN CORPORATION ..................................................................................................205 13.5.1
BUSINESS OVERVIEW...................................................................................................205
13.5.2
NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT.................................................205
13.5.3
PRODUCT PORTFOLIO...................................................................................................206
13.5.4
KEY STRATEGY..............................................................................................................206
13.5.5
RECENT DEVELOPMENTS..............................................................................................206
INTERNATIONAL TECHNIDYNE CORPORATION (ITC) ......................................................................208 13.6.1
BUSINESS OVERVIEW...................................................................................................208
13.6.2
KEY FINANCIALS...........................................................................................................208
13.6.3
PRODUCTS...................................................................................................................208
13.6.4
KEY STRATEGY..............................................................................................................208
13.6.5
RECENT DEVELOPMENTS..............................................................................................208
HELENA LABORATORIES .............................................................................................................209 17
© MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
13.8
13.9
13.10
13.11
MD 3255
13.7.1
BUSINESS OVERVIEW...................................................................................................209
13.7.2
KEY FINANCIALS...........................................................................................................209
13.7.3
PRODUCT PORTFOLIO...................................................................................................209
ALERE, INC. ................................................................................................................................210 13.8.1
BUSINESS OVERVIEW...................................................................................................210
13.8.2
ALERE, INC.: COMPANY SNAPSHOT ..............................................................................210
13.8.3
PRODUCT PORTFOLIO...................................................................................................210
13.8.4
KEY STRATEGY..............................................................................................................211
DIAGNOSTICA STAGO SAS ..........................................................................................................211 13.9.1
BUSINESS OVERVIEW...................................................................................................211
13.9.2
KEY FINANCIALS...........................................................................................................211
13.9.3
PRODUCT PORTFOLIO...................................................................................................211
13.9.4
KEY STRATEGY..............................................................................................................211
13.9.5
RECENT DEVELOPMENTS..............................................................................................212
INSTRUMENTATION LABORATORY (A DIVISION OF THE WERFEN GROUP) ......................................212 13.10.1
BUSINESS OVERVIEW...................................................................................................212
13.10.2
KEY FINANCIALS...........................................................................................................213
13.10.3
PRODUCT PORTFOLIO...................................................................................................213
13.10.4
KEY STRATEGY..............................................................................................................213
13.10.5
RECENT DEVELOPMENTS..............................................................................................213
THERMO FISHER SCIENTIFIC, INC. ..............................................................................................214 13.11.1
BUSINESS OVERVIEW...................................................................................................214
13.11.2
THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT .....................................................215
13.11.3
PRODUCT PORTFOLIO...................................................................................................215
13.11.4
KEY STRATEGIES ..........................................................................................................216
13.11.5
RECENT DEVELOPMENTS..............................................................................................216
14 APPENDIX .............................................................................................................. 217 14.1
INSIGHTS FROM INDUSTRY EXPERTS ..........................................................................................217
14.2
DISCUSSION GUIDE ...................................................................................................................217
14.3
COMPANY DEVELOPMENTS (2012–2014) ..................................................................................221 14.3.1
SYSMEX CORPORATION................................................................................................221
14.3.2
NIHON KOHEDEN CORPORATION ..................................................................................222
14.3.3
SIEMENS HEALTHCARE ................................................................................................222
14.3.4
DIAGNOSTICA STAGO, INC. ...........................................................................................222
14.3.5
INSTRUMENTATION LABORATORY (A DIVISION OF THE WERFEN GROUP) ........................223
14.4
INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE .................................................................223
14.5
AVAILABLE CUSTOMIZATIONS .....................................................................................................224
14.6
RELATED REPORTS .....................................................................................................................224
18 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
MD 3255
LIST OF TABLES U
TABLE 1
INCREASING ADOPTION OF AUTOMATED COAGULATION INSTRUMENTS BY DIAGNOSTIC LABORATORIES TO DRIVE THE COAGULATION ANALYZERS MARKET
49
HIGH COST OF FULLY AUTOMATED COAGULATION ANALYZERS RESTRAINING MARKET GROWTH
51
EMERGING MARKETS OFFER SIGNIFICANT POTENTIAL FOR COAGULATION ANALYZERS
52
STRINGENT REGULATORY POLICIES: A MAJOR CHALLENGE IN THE COAGULATION ANALYZERS MARKET
53
TABLE 5
COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2012–2019 ($MILLION)
63
TABLE 6
PROTHROMBIN TIME (PT/INR) TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
63
NORTH AMERICA: PROTHROMBIN TIME (PT/INR) TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
64
EUROPE: PROTHROMBIN TIME (PT/INR) TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
64
APAC: PROTHROMBIN TIME (PT/INR) TESTING MARKET SIZE, BY REGION, 2012– 2019 ($MILLION)
65
ACTIVATED CLOTTING TIME (ACT/APTT) TESTING MARKET SIZE, BY REGION, 2012– 2019 ($MILLION)
66
NORTH AMERICA: ACTIVATED CLOTTING TIME (ACT/APTT) TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
66
EUROPE: ACTIVATED CLOTTING TIME (ACT/APTT) TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
67
APAC: ACTIVATED CLOTTING TIME (ACT/APTT) TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
67
TABLE 14
D-DIMER TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
68
TABLE 15
NORTH AMERICA: D-DIMER TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
68
TABLE 16
EUROPE: D-DIMER TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
69
TABLE 17
APAC: D-DIMER TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
69
TABLE 18
FIBRINOGEN TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
70
TABLE 19
NORTH AMERICA: FIBRINOGEN TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
70
EUROPE: FIBRINOGEN TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
71
TABLE 21
APAC: FIBRINOGEN TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
71
TABLE 22
OTHER TESTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
72
TABLE 23
NORTH AMERICA: OTHER TESTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
72
TABLE 24
EUROPE: OTHER TESTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
73
TABLE 25
APAC: OTHER TESTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
73
TABLE 26
COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
77
TABLE 27
CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
79
CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
79
TABLE 2 TABLE 3 TABLE 4
TABLE 7 TABLE 8 TABLE 9 TABLE 10 TABLE 11 TABLE 12 TABLE 13
TABLE 20
TABLE 28
19 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
TABLE 29
MD 3255
NORTH AMERICA: CLINICALLABORATORY COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
79
EUROPE: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
80
APAC: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
80
TABLE 32
COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
82
TABLE 33
COAGULATION INSTRUMENTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
83
TABLE 34
NORTH AMERICA: COAGULATION INSTRUMENTS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
83
EUROPE: COAGULATION INSTRUMENTS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
84
APAC: COAGULATION INSTRUMENTS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
84
FULLY AUTOMATED COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2012– 2019 ($MILLION)
85
NORTH AMERICA: FULLY AUTOMATED COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
86
EUROPE: FULLY AUTOMATED COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
86
APAC: FULLY AUTOMATED COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
87
SEMI-AUTOMATED AND MANUAL COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
88
NORTH AMERICA: SEMI-AUTOMATED AND MANUAL COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
88
EUROPE: SEMI-AUTOMATED AND MANUAL COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
89
APAC: SEMI-AUTOMATED AND MANUAL COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
89
TABLE 45
COAGULATION CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
90
TABLE 46
COAGULATION CONSUMABLES MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
91
TABLE 47
NORTH AMERICA: COAGULATION CONSUMABLES MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
91
EUROPE: COAGULATION CONSUMABLES MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
91
APAC: COAGULATION CONSUMABLES MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
92
TABLE 50
COAGULATION REAGENTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
93
TABLE 51
NORTH AMERICA: COAGULATION REAGENTSMARKET SIZE, BY COUNTRY, 2012– 2019 ($MILLION)
93
EUROPE: COAGULATION REAGENTS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
94
APAC: COAGULATION REAGENTS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
94
COAGULATION STANDARDS, CALIBRATORS, AND CONTROLS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
95
NORTH AMERICA: COAGULATION STANDARDS, CALIBRATORS, AND CONTROLS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
96
EUROPE: COAGULATION STANDARDS, CALIBRATORS, AND CONTROLS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
96
TABLE 30 TABLE 31
TABLE 35 TABLE 36 TABLE 37 TABLE 38 TABLE 39 TABLE 40 TABLE 41 TABLE 42 TABLE 43 TABLE 44
TABLE 48 TABLE 49
TABLE 52 TABLE 53 TABLE 54 TABLE 55 TABLE 56
20 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
TABLE 57
MD 3255
APAC: COAGULATION STANDARDS, CALIBRATORS, AND CONTROLS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
97
POINT-OF-CARE TESTING COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
98
NORTH AMERICA: POINT-OF-CARE TESTING COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
99
EUROPE: POINT-OF-CARE TESTING COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
99
APAC: POINT-OF-CARE TESTING COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
100
TABLE 62
COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
105
TABLE 63
COAGULATION ANALYZERS MARKET SIZE FOR RESEARCH INSTITUTES, BY REGION, 2012–2019 ($MILLION)
106
NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE FOR RESEARCH INSTITUTES, BY COUNTRY, 2012–2019 ($MILLION)
107
EUROPE: COAGULATION ANALYZERS MARKET SIZE FOR RESEARCH INSTITUTES, BY COUNTRY, 2012–2019 ($MILLION)
107
APAC: COAGULATION ANALYZERS MARKET SIZE FOR RESEARCH INSTITUTES, BY COUNTRY, 2012–2019 ($MILLION)
108
COAGULATION ANALYZERS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY REGION, 2012–2019 ($MILLION)
109
NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2012–2019 ($MILLION)
109
EUROPE: COAGULATION ANALYZERS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2012–2019 ($MILLION)
110
APAC: COAGULATION ANALYZERS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2012–2019 ($MILLION)
110
COAGULATION ANALYZERS MARKET SIZE FOR STANDALONE HOSPITALS, BY REGION, 2012–2019 ($MILLION)
111
NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE FOR STANDALONE HOSPITALS, BY COUNTRY, 2012–2019 ($MILLION)
112
EUROPE: COAGULATION ANALYZERS MARKET SIZE FOR STANDALONE HOSPITALS, BY COUNTRY, 2012–2019 ($MILLION)
112
APAC: COAGULATION ANALYZERS MARKET SIZE FOR STANDALONE HOSPITALS, BY COUNTRY, 2012–2019 ($MILLION)
113
COAGULATION ANALYZERS MARKET SIZE FOR OTHERS, BY REGION, 2012–2019 ($MILLION)
114
NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE FOR OTHERS, BY COUNTRY, 2012–2019 ($MILLION)
115
EUROPE: COAGULATION ANALYZERS MARKET SIZE FOR OTHERS, BY COUNTRY, 2012–2019 ($MILLION)
115
APAC: COAGULATION ANALYZERS MARKET SIZE FOR OTHERS, BY REGION, 2012– 2019 ($MILLION)
116
TABLE 79
COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
119
TABLE 80
NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012– 2019 ($MILLION)
120
EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
120
APAC: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
121
TABLE 58 TABLE 59 TABLE 60 TABLE 61
TABLE 64 TABLE 65 TABLE 66 TABLE 67 TABLE 68 TABLE 69 TABLE 70 TABLE 71 TABLE 72 TABLE 73 TABLE 74 TABLE 75 TABLE 76 TABLE 77 TABLE 78
TABLE 81 TABLE 82
21 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
TABLE 83
MD 3255
NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 20122019 ($MILLION)
123
NORTH AMERICA: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
124
NORTH AMERICA: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012– 2019 ($MILLION)
124
TABLE 86
NORTH AMERICA: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
125
TABLE 87
NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012-2019 ($MILLION)
125
NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 20122019 ($MILLION)
126
U.S.: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
128
U.S.: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
128
U.S.: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
129
TABLE 92
U.S.: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
129
TABLE 93
U.S.: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)
130
U.S.: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
130
CANADA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
132
CANADA: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
132
CANADA: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
132
TABLE 98
CANADA: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
133
TABLE 99
CANADA: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)
133
CANADA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
134
EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
136
EUROPE: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
136
EUROPE: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
137
TABLE 104
EUROPE: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
137
TABLE 105
EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)
137
EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
138
GERMANY: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
139
GERMANY: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
140
GERMANY: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
140
GERMANY: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
141
TABLE 84 TABLE 85
TABLE 88 TABLE 89 TABLE 90 TABLE 91
TABLE 94 TABLE 95 TABLE 96 TABLE 97
TABLE 100 TABLE 101 TABLE 102 TABLE 103
TABLE 106 TABLE 107 TABLE 108 TABLE 109 TABLE 110
22 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
TABLE 111
MD 3255
GERMANY: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012– 2019 ($MILLION)
141
GERMANY: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
142
FRANCE: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
143
FRANCE: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
143
FRANCE: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
144
TABLE 116
FRANCE: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
144
TABLE 117
FRANCE: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)
144
FRANCE: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
145
U.K.: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
146
U.K.: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
146
U.K.: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
147
TABLE 122
U.K.: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
147
TABLE 123
U.K.: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)
148
U.K.: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
148
ITALY: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
149
ITALY: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
150
ITALY: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
150
TABLE 128
ITALY: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
151
TABLE 129
ITALY: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)
151
ITALY: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
152
SPAIN: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
153
SPAIN: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
153
SPAIN: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
154
TABLE 134
SPAIN: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
154
TABLE 135
SPAIN: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)
155
SPAIN: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
155
ROE: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
156
TABLE 112 TABLE 113 TABLE 114 TABLE 115
TABLE 118 TABLE 119 TABLE 120 TABLE 121
TABLE 124 TABLE 125 TABLE 126 TABLE 127
TABLE 130 TABLE 131 TABLE 132 TABLE 133
TABLE 136 TABLE 137
23 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
TABLE 138
MD 3255
ROE: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
157
ROE: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
157
TABLE 140
ROE: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
158
TABLE 141
ROE: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)
158
ROE: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
159
ASIA-PACIFIC: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
160
ASIA-PACIFIC: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
161
ASIA-PACIFIC: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
161
TABLE 146
ASIA-PACIFIC: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
162
TABLE 147
ASIA-PACIFIC: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012– 2019 ($MILLION)
162
ASIA-PACIFIC: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012– 2019 ($MILLION)
163
JAPAN: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
164
JAPAN: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
164
JAPAN: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
164
TABLE 152
JAPAN: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
165
TABLE 153
JAPAN: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)
165
JAPAN: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
166
CHINA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
167
CHINA: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
168
CHINA: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
168
TABLE 158
CHINA: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
169
TABLE 159
CHINA: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)
169
CHINA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
170
INDIA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
172
INDIA: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
172
INDIA: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
173
TABLE 164
INDIA: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
173
TABLE 165
INDIA: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)
174
TABLE 139
TABLE 142 TABLE 143 TABLE 144 TABLE 145
TABLE 148 TABLE 149 TABLE 150 TABLE 151
TABLE 154 TABLE 155 TABLE 156 TABLE 157
TABLE 160 TABLE 161 TABLE 162 TABLE 163
24 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
TABLE 166
MD 3255
INDIA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
174
ROAPAC: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
175
ROAPAC: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
176
ROAPAC: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
176
TABLE 170
ROAPAC: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
177
TABLE 171
ROAPAC: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)
177
ROA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
178
ROW: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
180
ROW: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
180
ROW: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
181
TABLE 176
ROW: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
181
TABLE 177
ROW: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)
182
ROW: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
182
TABLE 179
RECENT EXPANSION, 2012–2015
188
TABLE 180
RECENT NEW PRODUCT LAUNCHES, 2012–2015
189
TABLE 181
RECENT AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS, 2012–2015
190
TABLE 182
RECENT ACQUISITIONS, 2012-2015
191
TABLE 183
RECENT OTHER DEVELOPMENTS, 2014
191
TABLE 167 TABLE 168 TABLE 169
TABLE 172 TABLE 173 TABLE 174 TABLE 175
TABLE 178
25 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
MD 3255
LIST OF FIGURES FIGURE 1
COAGULATION ANALYZERS MARKET, BY PRODUCT
18
FIGURE 2
RESEARCH DESIGN
22
FIGURE 3
TOP-DOWN APPROACH
23
FIGURE 4
BOTTOM-UP APPROACH
24
FIGURE 5
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
25
FIGURE 6
DATA TRIANGULATION METHODOLOGY
25
FIGURE 7
NORTH AMERICA TO DOMINATE THE COAGULATION ANALYZERS MARKET
30
FIGURE 8
STANDALONE HOSPITALS SEGMENT WILL BE THE LARGEST END-USER SEGMENT IN THE COAGULATION ANALYZERS MARKET
32
FIGURE 9
COAGULATION ANALYZERS MARKET, BY GEOGRAPHY, 2014
32
FIGURE 10
POINT-OF-CARE TESTING ANALYZERS SEGMENT TO GROW AT THE HIGHEST CAGR
35
FIGURE 11
CONSUMABLES SEGMENT HELD THE LARGEST MARKET SHARE IN 2014
36
FIGURE 12
U.S. COMMANDS THE LARGEST SHARE OF THE MARKET
37
FIGURE 13
FULLY AUTOMATED ANALYZERS SEGMENT DOMINATES MARKET
38
FIGURE 14
PT/INR SEGMENT DOMINATES THE MARKET
39
FIGURE 15
STANDALONE HOSPITALS WILL CONTINUE TO LEAD THE COAGULATION ANALYZERS END-USERS MARKET DURING THE FORECAST PERIOD
40
FIGURE 16
ASIA TO WITNESS HIGH GROWTH DURING FORECAST PERIOD
41
FIGURE 17
COAGULATION ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
46
FIGURE 18
PORTER’S FIVE FORCES ANALYSIS
54
FIGURE 19
SUPPLY CHAIN ANALYSIS
57
FIGURE 20
STRATEGIC BENCHMARKING: SYSMEX CORPORATION LARGELY ADOPTED ORGANIC GROWTH STRATEGIES TO ENHANCE ITS PRODUCT OFFERINGS
59
PT/INR SEGMENT WILL CONTINUE TO DOMINATE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
62
CONSUMABLES SEGMENT WILL DRIVE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
78
FULLY AUTOMATED ANALYZERS SEGMENT IS THE FASTEST-GROWING SEGMENT DURING THE FORECAST PERIOD
81
ASIA IS THE FASTEST-GROWING REGION IN POINT-OF-CARE TESTING COAGULATION ANALYZERS MARKET DURING FORECAST PERIOD
97
PHOTO OPTICAL TECHNOLOGY ACCOUNTED FOR THE LARGEST SHARE OF THE COAGULATION ANALYZERS MARKET, BY TECHNOLOGY
102
THE STANDALONE HOSPITALS SEGMENT IS EXPECTED TO DRIVE THE GROWTH OF THE COAGULATION ANALYZERS MARKET IN THE FORECAST PERIOD
105
GEOGRAPHIC SNAPSHOT (2014): EMERGING MARKETS HOLD SIGNIFICANT GROWTH OPPORTUNITIES FOR COAGULATION ANALYZERS
118
THE CONSUMABLES SEGMENT WILL CONTINUE TO DRIVE THE COAGULATION ANALYZERS MARKET IN THE FORECAST PERIOD
119
INCREASING INVESTMENTS FOR THE DEVELOPMENT OF COAGULATION ANALYZERS ARE DRIVING MARKET GROWTH
123
GERMANY WILL CONTINUE TO DOMINATE THE EUROPEAN COAGULATION ANALYZERS MARKET IN THE FORECAST PERIOD
135
FIGURE 21 FIGURE 22 FIGURE 23 FIGURE 24 FIGURE 25 FIGURE 26 FIGURE 27 FIGURE 28 FIGURE 29 FIGURE 30
26 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
FIGURE 31 FIGURE 32 FIGURE 33 FIGURE 34 FIGURE 35 FIGURE 36 FIGURE 37 FIGURE 38
MD 3255
COAGULATION ANALYZERS MARKET IN ASIA-PACIFIC TO GROW AT THE HIGHEST CAGR
159
CLINICAL LABORATORY ANALYZERS MARKET IN INDIA HAS HIGH GROWTH POTENTIAL
171
THE CONSUMABLES SEGMENT WILL DOMINATE THE ROW CLINICAL LABORATORY ANALYZERS MARKET IN 2019
178
NEW PRODUCT LAUNCHES WAS THE PREFERRED STRATEGY FOR MAJOR PLAYERS IN THE COAGULATION ANALYZERS MARKET
184
GLOBAL CLINICAL LABORATORY ANALYZERS MARKET SHARE, BY KEY PLAYER, 2014
185
GLOBAL POINT-OF-CARE COAGULATION ANALYZERS MARKET SHARE, BY KEY PLAYER, 2014
186
BATTLE FOR MARKET SHARE: EXPANSION WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS
187
GEOGRAPHIC REVENUE MIX FOR TOP 3 MARKET PLAYERS
193
27 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
MD 3255
SAMPLE TABLES TABLE 1
EUROPE: COAGULATION ANALYZERS MARKET SIZE FOR STANDALONE HOSPITALS, BY COUNTRY, 2012–2019 ($MILLION) Country
2012
2013
2014-e
2019-p
CAGR% (2014–2019)
Germany
XX
XX
XX
XX
XX
France
XX
XX
XX
XX
XX
U.K.
XX
XX
XX
XX
XX
Italy
XX
XX
XX
XX
XX
Spain
XX
XX
XX
XX
XX
Rest of Europe
XX
XX
XX
XX
XX
Total
XX
XX
XX
XX
XX
e – Estimated; p – Projected Source: Annual Reports, SEC Filings, Press Releases, Investor Presentations, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), American Society for Clinical Pathology (ASCP), American Association for Clinical Chemistry (AACC), USChina Point of Care Testing (POCT) Forum, Asian-Pacific Society of Thrombosis and Hemostasis (APSTH), U.S. Department of Health & Human Services (HHS), International Society on Thrombosis and Haemostasis (ISTH), Canadian Institute for Health Information (CIHI), American Thrombosis and Hemostasis Network (ATHN), Foundation for Innovative New Diagnostics(FIND), National Health Service (NHS), Expert Interviews, and MarketsandMarkets Analysis
Germany commanded the largest share of XX% of the European coagulation analyzers market for standalone hospitals in 2014. This segment is poised to reach $XX million by 2019 from $XX million in 2014, at a CAGR of XX% from 2014 to 2019.
TABLE 2
NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE FOR OTHERS, BY COUNTRY, 2012–2019 ($MILLION) Country
2012
2013
2014-e
2019-p
CAGR% (2014–2019)
U.S.
XX
XX
XX
XX
XX
Canada
XX
XX
XX
XX
XX
Total
XX
XX
XX
XX
XX
e – Estimated; p – Projected Source: Annual Reports, SEC Filings, Press Releases, Investor Presentations, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), American Society for Clinical Pathology (ASCP), American Association for Clinical Chemistry (AACC), USChina Point of Care Testing (POCT) Forum, Asian-Pacific Society of Thrombosis and Hemostasis (APSTH), U.S. Department of Health & Human Services (HHS), International Society on Thrombosis and Haemostasis (ISTH), Canadian Institute for Health Information (CIHI), American Thrombosis and Hemostasis Network (ATHN), Foundation for Innovative New Diagnostics(FIND), National Health Service (NHS), Expert Interviews, and MarketsandMarkets Analysis
The U.S. commanded the largest share of XX% of the North American coagulation analyzers market for others in 2014. This segment is poised to reach $XX million by 2019 from $XX million in 2014, at a CAGR of XX% from 2014 to 2019.
28 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
TABLE 3
MD 3255
NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) Country
2012
2013
2014-e
CAGR% (2014–2019)
2019-p
U.S.
XX
XX
XX
XX
XX
Canada
XX
XX
XX
XX
XX
Total
XX
XX
XX
XX
XX
Source: Annual Reports, SEC Filings, Press Releases, Investor Presentations, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), American Society for Clinical Pathology (ASCP), American Association for Clinical Chemistry (AACC), USChina Point of Care Testing (POCT) Forum, Asian-Pacific Society of Thrombosis and Hemostasis (APSTH), U.S. Department of Health & Human Services (HHS), International Society on Thrombosis and Haemostasis (ISTH), Canadian Institute for Health Information (CIHI), American Thrombosis and Hemostasis Network (ATHN), Foundation for Innovative New Diagnostics(FIND), National Health Service (NHS), Expert Interviews, and MarketsandMarkets Analysis
The U.S. commanded the largest share of XX% of the North American coagulation analyzers market in 2014. It is poised to reach $XX million by 2019 from $XX million in 2014, at a CAGR of XX% from 2014 to 2019.
29 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market – Forecast to 2019
MD 3255
RELATED REPORTS Report Title
Published Date
Hematology Analyzers & Reagents Market 1
by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users (Research Institute, Hospital, & Clinical Testing Labs) - Global Forecasts to 2019
May 2014
http://www.marketsandmarkets.com/Market-Reports/hematology-analyzers-reagentsmarket-153222146.html
In Vitro Diagnostic (IVD) Market 2
[Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] – Forecast To 2017
July 2013
http://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market703.html
Point-Of-Care Diagnostics / Testing Market 3
by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018
September 2014
http://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market106829185.html
30 © MarketsandMarkets
Coagulation/Hemostasis Analyzer Market â&#x20AC;&#x201C; Forecast to 2019
MD 3255
Disclaimer: MarketsandMarkets strategic analysis services are limited publications containing valuable market information provided to a select group of customers in response to orders. Our customers acknowledge, when ordering, that MarketsandMarkets strategic analysis services are for our customersâ&#x20AC;&#x2122; internal use and not for general publication or disclosure to third parties. Quantitative market information is based primarily on interviews and therefore, is subject to fluctuation. MarketsandMarkets does not endorse any vendor, product or service depicted in its research publications. MarketsandMarkets strategic analysis publications consist of the opinions of MarketsandMarkets' research and should not be construed as statements of fact. MarketsandMarkets disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. MarketsandMarkets takes no responsibility for any incorrect information supplied to us by manufacturers or users. All trademarks, copyrights and other forms of intellectual property belong to their respective owners and may be protected by copyright. Under no circumstance may any of these be reproduced in any form without the prior written agreement of their owner. No part of this strategic analysis service may be given, lent, resold or disclosed to non-customers without written permission. Reproduction and/or transmission in any form and by any means including photocopying, mechanical, electronic, recording or otherwise, without the permission of the publisher is prohibited.
For information regarding permission, contact: Tel: 1-888-600-6441 Email: sales@marketsandmarkets.com
31 Š MarketsandMarkets